The Howard Hughes Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for The Howard Hughes in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" The Howard Hughes stock.
View analyst ratings for The Howard Hughes or view top-rated stocks.

Wall Street analysts have given The Howard Hughes a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but The Howard Hughes wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

The Howard Hughes is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for The Howard Hughes.

The Howard Hughes will be holding an earnings conference call on Thursday, August 5th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "10150079".

The Howard Hughes Co. (NYSE:HHC) issued its quarterly earnings data on Sunday, May, 9th. The financial services provider reported ($1.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.57) by $0.63. The financial services provider had revenue of $190.58 million for the quarter, compared to analysts' expectations of $189.13 million. The Howard Hughes had a net margin of 4.53% and a trailing twelve-month return on equity of 2.12%. The Howard Hughes's revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the prior year, the company posted ($2.88) earnings per share.
View The Howard Hughes' earnings history.

The Howard Hughes' stock was trading at $89.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, HHC shares have increased by 3.2% and is now trading at $91.83.
View which stocks have been most impacted by COVID-19.

3 analysts have issued 12 month target prices for The Howard Hughes' stock. Their forecasts range from $82.00 to $150.00. On average, they expect The Howard Hughes' share price to reach $115.67 in the next twelve months. This suggests a possible upside of 26.0% from the stock's current price.
View analysts' price targets for The Howard Hughes or view top-rated stocks among Wall Street analysts.

Some companies that are related to The Howard Hughes include Healthpeak Properties (PEAK), Duke Realty (DRE), Boston Properties (BXP), VICI Properties (VICI), UDR (UDR), Equity LifeStyle Properties (ELS), Camden Property Trust (CPT), W. P. Carey (WPC), American Homes 4 Rent (AMH), Iron Mountain (IRM), Medical Properties Trust (MPW), Annaly Capital Management (NLY), Sino Land (SNLAY), Host Hotels & Resorts (HST) and VEREIT (VER).
View all of HHC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other The Howard Hughes investors own include Gilead Sciences (GILD), NVIDIA (NVDA), Esperion Therapeutics (ESPR), The Walt Disney (DIS), Carnival Co. & (CCL), AT&T (T), CVS Health (CVS), QUALCOMM (QCOM), Johnson & Johnson (JNJ) and Alibaba Group (BABA).

The Howard Hughes trades on the New York Stock Exchange (NYSE) under the ticker symbol "HHC."

The Howard Hughes' stock is owned by many different retail and institutional investors. Top institutional shareholders include Real Estate Management Services LLC (0.07%), Karpas Strategies LLC (0.02%) and Harel Insurance Investments & Financial Services Ltd. (0.00%). Company insiders that own The Howard Hughes stock include Adam R Flatto, Allen J Model, Douglas Johnstone, Greg Fitchitt, James Carman, Jeffrey D Furber, Kevin Orrock, Paul H Layne, Pershing Square Capital Manage, Peter F Riley and Sarah M Vasquez.
View institutional ownership trends for The Howard Hughes.

HHC stock was sold by a variety of institutional investors in the last quarter, including Real Estate Management Services LLC, and Karpas Strategies LLC. Company insiders that have sold The Howard Hughes company stock in the last year include Allen J Model, Douglas Johnstone, James Carman, and Peter F Riley.
View insider buying and selling activity for The Howard Hughes or view top insider-selling stocks.

HHC stock was purchased by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd.. Company insiders that have bought The Howard Hughes stock in the last two years include Adam R Flatto, Allen J Model, Greg Fitchitt, Jeffrey D Furber, Paul H Layne, and Pershing Square Capital Manage.
View insider buying and selling activity for The Howard Hughes or or view top insider-buying stocks.

Shares of HHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HHC stock can currently be purchased for approximately $91.83.

The Howard Hughes has a market capitalization of $5.06 billion and generates $699.49 million in revenue each year. The financial services provider earns $-26,150,000.00 in net income (profit) each year or $0.81 on an earnings per share basis.

The Howard Hughes employs 600 workers across the globe.

The Howard Hughes was founded in 2011.

The official website for The Howard Hughes is www.howardhughes.com.

The Howard Hughes is headquartered at 13355 Noel Road 22nd Floor, DALLAS TX, 75240.

The Howard Hughes' mailing address is 13355 Noel Road 22nd Floor, DALLAS TX, 75240. The financial services provider can be reached via phone at 214-741-7744 or via email at [email protected]